{Reference Type}: Journal Article
{Title}: SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).
{Author}: Morán LO;Mateo FJP;Balanyà RP;Revuelta JR;Martínez SR;Fombella JPB;Vázquez EMB;Caro NL;Langa JM;Fernández MS;
{Journal}: Clin Transl Oncol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 7
{Factor}: 3.34
{DOI}: 10.1007/s12094-024-03605-2
{Abstract}: The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this new update to the guidelines, SEOM seeks to incorporate recent evidence, based on a critical review of the literature, to provide practical current recommendations for the prophylactic and therapeutic management of VTE in patients with cancer. Special clinical situations whose management and/or choice of currently recommended therapeutic options (low-molecular-weight heparins [LMWHs] or direct-acting oral anticoagulants [DOACs]) is controversial are included.